These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39181316)

  • 21. Exploring the role of m6A modification in the great obstetrical syndromes.
    Ning J; Yan J; Yang H
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2234541. PubMed ID: 37474299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
    Fang X; Li M; Yu T; Liu G; Wang J
    Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
    Liu WW; Wang H; Zhu XY
    Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-methyladenosine links RNA metabolism to cancer progression.
    Dai D; Wang H; Zhu L; Jin H; Wang X
    Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy.
    Shi JX; Zhang ZC; Yin HZ; Piao XJ; Liu CH; Liu QJ; Zhang JC; Zhou WX; Liu FC; Yang F; Wang YF; Liu H
    Mol Cancer; 2024 Sep; 23(1):213. PubMed ID: 39342168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of N6-methyladenosine RNA modification in gastric cancer.
    Ding SQ; Zhang XP; Pei JP; Bai X; Ma JJ; Zhang CD; Dai DQ
    Cell Death Discov; 2023 Jul; 9(1):241. PubMed ID: 37443100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA m6A methylation regulators in sepsis.
    Zhu L; Zhang H; Zhang X; Xia L
    Mol Cell Biochem; 2024 Sep; 479(9):2165-2180. PubMed ID: 37659034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of N6-methyladenosine (m6A) in eye diseases.
    Gao JF; Zhang L
    Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours.
    Xia Z; Kong F; Wang K; Zhang X
    Front Pharmacol; 2022; 13():908079. PubMed ID: 35754499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.
    Ye F; Wu J; Zhang F
    Biochem Biophys Res Commun; 2023 Jan; 638():1-6. PubMed ID: 36434904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
    Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
    Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.
    He C; Teng X; Wang L; Ni M; Zhu L; Liu J; Lv W; Hu J
    Mol Biol Rep; 2023 Oct; 50(10):8691-8703. PubMed ID: 37598390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis.
    Ma W; Wu T
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1190-C1205. PubMed ID: 36036444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of N6-methyladenosine (m
    Elsabbagh RA; Rady M; Watzl C; Abou-Aisha K; Gad MZ
    Cell Commun Signal; 2022 Sep; 20(1):140. PubMed ID: 36085064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Roles of RNA N6-methyladenosine Modifications in Systemic Lupus Erythematosus.
    Xia X; Qu R
    Cell Biochem Biophys; 2024 Dec; 82(4):3223-3234. PubMed ID: 39095568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel insights into the interplay between m6A modification and programmed cell death in cancer.
    Chen J; Ye M; Bai J; Hu C; Lu F; Gu D; Yu P; Tang Q
    Int J Biol Sci; 2023; 19(6):1748-1763. PubMed ID: 37063421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of N6-methyladenosine modification in the development of Parkinson's disease.
    Zhou J; Han Y; Hou R
    Front Cell Dev Biol; 2023; 11():1321995. PubMed ID: 38155838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
    Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.